Bâtiment Synathlon, quartier UNIL-Centre
Lausanne, 1015, Switzerland
NCT Number: NCT05350566
The main objective of this study is to determine the effectiveness of a nutritional intervention (olive leaf extract) combined with a specific training session (MICT or SIT) on PDH activation (as well as other protein expressions) and exercise-induced muscle fatigue.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
Lausanne, 1015, Switzerland
Sprint interval training (SIT) is a form of interval training characterised by short bursts of intense exercise interspersed with rest periods. SIT is as, or more, effective than moderate intensity continuous training (MICT) for systemic and metabolic adaptations of muscles, despite a lower workload and shorter duration. However, the mechanisms underlying the metabolic response to SIT versus MICT are poorly understood. Our recent work (Zanou et al. 2021) suggests that increased pyruvate dehydrogenase (PDH) activity may explain why a SIT session led to greater changes in proteins involved in mitochondrial respiration compared to a MICT session.
Recently, it was found that a natural and commercially available compound based on olive leaf extract could stimulate resting mitochondrial bioenergetics by activating the mitochondrial calcium uniporter (MCU), which is involved in calcium transport across the mitochondrial membrane, directly controlling PDH activity. The main objective of this study is to determine the effectiveness of an acute nutritional intervention (olive leaf extract) combined with a specific training session (MICT or SIT) on PDH activation (as well as other protein expressions) and exercise-induced muscle fatigue.
Participants will be allocated to either a SIT (6 x 30 s all out sprints) or a MICT (1h at 50% maximal aerobic power) group and asked to come to the laboratory for five visits including one familiarization session with a triangular test for maximal aerobic power determination, the first experimental session during which they will realize the exercise with the product or a placebo and a session 24h after to assess skeletal muscle adaptations. Then after a 3 week wash-out period, they report to the laboratory for the fourth and fifth session, identical to the second and third sessions but with the other intervention (product or placebo). Muscle microbiopsies will be collected from the vastus lateralis muscle before, immediately after and 24 hours after exercise (MICT or SIT), while knee extensor neuromuscular function will be assessed at the same time points using voluntary and electrically-evoked contractions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A capsule containing 250 mg of an olive leaf extract preparation will be swallowed with a glass of water before exercise.
A capsule containing 336 mg of cellulose microcrystalline will be swallowed with a glass of water before exercise.
Time frame: before, immediately after and 24 hours after exercise completion
protein involved in skeletal muscle metabolism
Time frame: before, immediately after and 24 hours after exercise completion
proteins used as markers of oxidative phosphorylation complexes
Time frame: before, immediately after and 24 hours after exercise completion
protein involved in the transport of Ca2+ in the mitochondria
Time frame: before, immediately after and 24 hours after exercise completion
Maximal force of the knee extensor muscles
Time frame: before, immediately after and 24 hours after exercise completion
overall index of central fatigue induced by exercise
Time frame: before, immediately after and 24 hours after exercise completion
overall index of peripheral fatigue induced by exercise
Time frame: before, immediately after and 24 hours after exercise completion
index of neuromuscular excitability
University of Lausanne
Other
Acronym: NUTSPORT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details